DR. SIMONE GÜNTHER

  • Promotion in Biologie an der Universität Karlsruhe / D, KIT- Botanisches Institut für Molekularbiologie und Biochemie, Prof. Hartmut K. Lichtenthaler

  • Post Doc, Yale University / USA, Biological and Biomedical Sciences (BBS): Plant Molecular Biology. Prof. Stephen L. Dellaporta

  • Profit by Difference Coach® in einer Ausbildung bei Dr. Peter Modler

     

Senior Director Business & Medical Affairs, QIAGEN,

Team Leading Function (11 FTE)
Business Ownership for the Oncology Portfolio, > 50 M$
Business Product Marketing and Product Portfolio Management for the MDX Oncology Assay & NGS Business
GTM responsibility with full commercial accountability Leading the Biomarker team

 

Director Market Development & Business Strategy, THERMO FISHER SCIENTIFIC

Global Responsibilities, Team Leading Function (12 FTE)
Building new product concept – community panel program, enabling to launch RUO clinical content
Building a new product development process – via KOL/Falcon Developer networks
Building a new GTM process to drive local acceptance according to local accreditation requirements; 40 – 60% market penetration within the first 12 month after product launch

 

Senior Manager Application Support, APPLIED BIOSYSTEMS

European Responsibilities, Team Leading Function (7 FTE)
Drive NPS and customer intimacy index up to above 65% by building knowledge centers within the Fields Application Force

 

Member of the Scientific Advisory Board of APPLIED BIOSYSTEMS

Responsible to develop the 5–10 year scientific vision of the company
Recommendation for M&A
Collaboration with the Board of Directors on scientific and technical vision

REFERENZEN

The Genereader® System

Erste vollständiger Next-Generation-Sequencing-Lösung im klinischen Segment. Vom Einzelgerät zur System-Lösung: Kernstrategie zur Neupositionierung in einem bereits besetzen Marktsegment.
www.youtube.com

 

Proof of Principle

EHEC-Ausbruch in Deutschland 2011: Use Case-Demonstration unter Notfallbedingungen.
www.youtube.com @ 2:40min
www.youtube.com

 

Das Falcon Team

Disruptive Innovation im klinischen Alltag 2011–2013. Von der technischen Innovation zur klinisch einsetzbaren Lösung. Entwicklung eines neuen Produktentwicklung- und Go-to-Market Konzept.
www.thermofisher.com
www.prnewswire.com

 

Präimplantationsdiagnostik / Ion Torrent PGM®

Wie aus Technologietrends neue Geschäftsfelder entstehen können.
www.youtube.com

 

STUDIEN und weiterführende Links

McKinsey report – Woman matter, Jan 2008

McKinsey report – Delivering trough diversity, Jan 2018

KONTAKTFORMULAR

Schön, dass Sie uns kontaktieren

Erforderlich
Erforderlich

KONTAKT

EMC² @ LAKE CONSTANCE
Am Erlenbach 6
88662 Überlingen

Web: www.emc2lc.de
Email: sg@emc2lc.de

Telefon: +49 7551 97 06 71
Mobil: +49 176 82 20 66 11